Skip to main navigation
menu
Aclaris - Corp Menu
About Us
»
« Back
Overview
Leadership
Board of Directors
Scientific Advisory Board
Corporate Compliance
Contact
Research
»
« Back
Diseases and Conditions
Drug Development Pipeline
Drug Discovery
Clinical Trials
Publications
Investigator Initiated Studies
Partnerships
Careers
Citizenship
»
« Back
Social Responsibility
Scientist Development Program
Aclaris Support
Insights
Investors
»
« Back
Investor Overview
Stock Information
Press Releases
Events
Investor Presentations
SEC Filings
Corporate Governance
Investor FAQs
Email Alerts
Aclaris - Extras Menu
Media resources
Contact us
Aclaris - Corp Menu
About Us
»
« Back
Overview
Leadership
Board of Directors
Scientific Advisory Board
Corporate Compliance
Contact
Research
»
« Back
Diseases and Conditions
Drug Development Pipeline
Drug Discovery
Clinical Trials
Publications
Investigator Initiated Studies
Partnerships
Careers
Citizenship
»
« Back
Social Responsibility
Scientist Development Program
Aclaris Support
Insights
Investors
»
« Back
Investor Overview
Stock Information
Press Releases
Events
Investor Presentations
SEC Filings
Corporate Governance
Investor FAQs
Email Alerts
Aclaris - Investor Relations
Investor Overview
Stock Information
Press Releases
Events
SEC Filings
Corporate Governance
Investor Presentations
Investor FAQs
Email Alerts
Investor Contact
For investor related questions, please email
investors@aclaristx.com
Biography
Bryan Reasons
Chair of the Audit
